Neuroimaging Biomarkers for Drug Discovery and Development in Schizophrenia.

Preller KH, Scholpp J, Wunder A, Rosenbrock H

DOI: 10.1016/j.biopsych.2024.01.009
Published: 2024 Oct 15
Container: Biological psychiatry
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.biopsych.2024.01.009,
  title = {Neuroimaging Biomarkers for Drug Discovery and Development in Schizophrenia.},
  author = {Preller KH and Scholpp J and Wunder A and Rosenbrock H},
  year = {2024},
  journal = {Biological psychiatry},
  doi = {10.1016/j.biopsych.2024.01.009},
  url = {https://doi.org/10.1016/j.biopsych.2024.01.009}
}

RIS

TY  - JOUR
TI  - Neuroimaging Biomarkers for Drug Discovery and Development in Schizophrenia.
AU  - Preller KH
AU  - Scholpp J
AU  - Wunder A
AU  - Rosenbrock H
PY  - 2024
JO  - Biological psychiatry
DO  - 10.1016/j.biopsych.2024.01.009
UR  - https://doi.org/10.1016/j.biopsych.2024.01.009
ER  -

APA

KH, P., J, S., A, W., & H, R. (2024). Neuroimaging Biomarkers for Drug Discovery and Development in Schizophrenia.. Biological psychiatry. https://doi.org/10.1016/j.biopsych.2024.01.009

Source records

pubmed · retrieved 2026-09-27T08:41:24.649Z
europe-pmc · retrieved 2026-09-27T08:41:24.654Z